Vertex Pharmaceuticals Inc. stock rises Friday, still underperforms market
This was the stock's third consecutive day of gains.
Levi & Korsinsky Reminds Vertex Pharmaceuticals Investors of the Ongoing Investigation into Potential Violations of Securities Laws - VRTX
NEW YORK, NY / ACCESSWIRE / January 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...
MarketWatch14d
Vertex Gets Expanded FDA Approval for Cystic Fibrosis Treatment
Vertex Pharmaceuticals said Friday the U.S. Food and Drug Administration expanded its approval of a cystic fibrosis treatment, encompassing more patients with different types of mutations of the ...
Stockhouse14d
Vertex Pharmaceuticals Incorporated Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - VRTX
NEW YORK, NY / ACCESSWIRE / December 20, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") ...
Investing14d
Vertex Pharmaceuticals announces FDA approval for ALYFTREK
The announcement comes directly from Vertex Pharmaceuticals (NASDAQ ... threatening condition that affects the lungs and digestive system. This approval will allow many of the patients with ...
Nasdaq14d
Vertex Pharmaceuticals price target lowered to $520 from $566 at BMO Capital
BMO Capital lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $520 from $566 but keeps an Outperform rating on the shares. The company’s Suzetrigine Phase 2 LSR ...
Reuters14d
US FDA approves Vertex Pharma's triple combo cystic fibrosis treatment
Dec 20 (Reuters) - The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals ... the Central American nation's banking system, which would give the state control over appointing ...
Hosted on MSN14d
Cramer’s Mad Dash: Vertex Pharmaceuticals
CNBC’s Jim Cramer delivers his daily Mad Dash. Luigi Mangione, CEO killing suspect, pleads not guilty to state terror and murder charges in Manhattan court Congress ...
ETF Daily News14d
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Shares Sold by Public Employees Retirement System of Ohio
Apellis Pharmaceuticals Stock Down 2.6 % APLS opened at $33.14 on Friday. The company has a debt-to-equity ratio of 1.91, a quick ratio of 3.73 and a current ratio of 4.36. The company has a ...
cweb14d
Vertex Pharmaceuticals’ Stock Performance and Market Outlook
Vertex Pharmaceuticals (NASDAQ:VRTX) faces a potential downside in its stock price, as indicated by RBC Capital’s price target. The company’s stock experienced a significant decline following ...
Insider Monkey15d
Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX): ‘I Think You Should Buy The Dip Here’
In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other stocks Jim Cramer talked about this week. Jim Cramer, host of Mad ...